Safety and efficacy of modified live feline Toxoplasma gondii vaccine.
Choromanski
L
L
Miles, Inc., Agriculture Division, Shawnee Mission, KS, USA.
Freyre
A
A
Popiel
R
R
Brown
K
K
Grieve
R
R
Shibley
G
G
D000284:Administration, Oral; D000818:Animals; D002371:Cat Diseases / Q000517:prevention & control*; D002415:Cats; D005260:Female; D005819:Genetic Markers; D006801:Humans; D016582:Leukemia, Feline / Q000276:immunology; D008297:Male; D016052:Protozoan Vaccines / Q000009:adverse effects* / Q000302:isolation & purification / Q000494:pharmacology*; D012307:Risk Factors; D012449:Safety; D014122:Toxoplasma / Q000254:growth & development / Q000276:immunology* / Q000302:isolation & purification; D014123:Toxoplasmosis / Q000517:prevention & control / Q000635:transmission; D014124:Toxoplasmosis, Animal / Q000517:prevention & control*
D005819:Genetic Markers; D016052:Protozoan Vaccines